Connect
MJA
MJA

Endocrine system diseases

Letters

Two decades of increasing incidence of childhood‐onset type 2 diabetes in Western Australia (2000–2019)

Aveni Haynes, Jacqueline A Curran and Elizabeth A Davis

Med J Aust 2021; 214 (6): 285-285.e1

Letters

Alternative screening protocols may miss most cases of gestational diabetes mellitus during the COVID‐19 pandemic

Michael C d'Emden, Jacobus PJ Ungerer and Susan J Jersey

Med J Aust 2021; 214 (6): 284-284.e1 Free

Perspectives

Technologies in the management of type 1 diabetes

Jennifer R Snaith and D Jane Holmes‐Walker

Med J Aust 2021; 214 (5): 202-205.e1

Letters

Sodium–glucose cotransporter type 2 inhibitors: managing the small but critical risk of diabetic ketoacidosis

Emily J Meyer, Venkatesan Thiruvenkatarajan and David Jesudason

Med J Aust 2021; 214 (2): 93-93.e1

Letters

Sodium–glucose cotransporter type 2 inhibitors: managing the small but critical risk of diabetic ketoacidosis

Peter S Hamblin, Rosemary Wong and Leon A Bach

Med J Aust 2021; 214 (2): 94-94.e1

Letter

Hypothyroidism: a TV diagnosis to remember

Timothy A Welborn

Med J Aust 2020; 213 (11): 515-515.e1

Editorials

Red‐flagging the prescribing of oral corticosteroids for people with asthma

Christine F McDonald and Christopher J Worsnop

Med J Aust 2020; 213 (7): 313-314

Letters

Possible link between obesity and severe COVID‐19

John Dyett

Med J Aust 2020; 213 (8): 380-380.e1 Free

Letters

Risk of undetected cases of gestational diabetes mellitus during the COVID‐19 pandemic

Ranita Siru, Johan H Conradie, Melissa J Gillett, Emily Gianatti and Michael M Page

Med J Aust 2020; 213 (7): 335-335.e1 Free

Medical education / Lessons from practice

The dangers of herbal teas: hypertension and weakness caused by liquorice‐induced apparent mineralocorticoid excess

Ravind Pandher, Anita Puvanendran and Terrence H Diamond

Med J Aust 2020; 213 (5): 207-208.e1

Letters

Estimating the magnitude of cancer overdiagnosis in Australia

Diana L Learoyd

Med J Aust 2020; 213 (4): 189-189.e1

Letters

Estimating the magnitude of cancer overdiagnosis in Australia

Paul P Glasziou, Katy JL Bell and Alexandra L Barratt

Med J Aust 2020; 213 (4): 189-189.e1

Letters

Routine glucose assessment in the emergency department for detecting unrecognised diabetes: a cluster randomised trial

Spiros Fourlanos, Rahul Barmanray and Mervyn Kyi

Med J Aust 2020; 213 (2): 95-95.e1

Letters

Routine glucose assessment in the emergency department for detecting unrecognised diabetes: a cluster randomised trial

N Wah Cheung, Lesley V Campbell and Sandy Middleton

Med J Aust 2020; 213 (2): 95-95.e1

Guidelines

Screening, assessment and management of type 2 diabetes mellitus in children and adolescents: Australasian Paediatric Endocrine Group guidelines

Alexia S Peña, Jacqueline A Curran, Michelle Fuery, Catherine George, Craig A Jefferies, Kristine Lobley, Karissa Ludwig, Ann M Maguire, Emily Papadimos, Aimee Peters, Fiona Sellars, Jane Speight, Angela Titmuss, Dyanne Wilson, Jencia Wong, Caroline Worth and Rachana Dahiya

Med J Aust 2020; 213 (1): 30-43

Perspectives

Sodium–glucose cotransporter type 2 inhibitors: managing the small but critical risk of diabetic ketoacidosis

Peter S Hamblin, Rosemary Wong and Leon A Bach

Med J Aust 2020; 212 (7): 294-296.e1

Perspective

Breathing life into Australian diabetes clinical guidelines

Heath White, Britta Tendal, Julian Elliott, Tari Turner, Sofianos Andrikopoulos and Sophia Zoungas

Med J Aust 2020; 212 (6): 250-251.e1

Narrative review

Advances in type 2 diabetes therapy: a focus on cardiovascular and renal outcomes

Renata Libianto, Timothy ME Davis and Elif I Ekinci

Med J Aust 2020; 212 (3): 133-139

Letters

Clinical characteristics of Western Australian children diagnosed with type 2 diabetes before 10 years of age

Jacqueline A Curran, Aveni Haynes and Elizabeth A Davis

Med J Aust 2020; 212 (2): 95-95.e1

Letters

Euglycaemic ketoacidosis from an SGLT2 inhibitor exacerbated by a ketogenic diet

Shampa Sinha, Daniel Gavaghan and Steven Yew

Med J Aust 2020; 212 (1): 46-46.e1

Editorial

Inpatient diabetes care requires adequate support, not just HbA1c screening

Matthew JL Hare and Jonathan E Shaw

Med J Aust 2019; 211 (10): 452-453

Research

Routine glucose assessment in the emergency department for detecting unrecognised diabetes: a cluster randomised trial

N Wah Cheung, Lesley V Campbell, Gregory R Fulcher, Patrick McElduff, Barbara Depczynski, Shamasunder Acharya, John Carter, Bernard Champion, Roger Chen, David Chipps, Jeff Flack, Jen Kinsella, Margaret Layton, Mark McLean, Robert G Moses, Kris Park, Ann M Poynten, Carol Pollock, Debbie Scadden, Katherine T Tonks, Mary Webber, Chris White, Vincent Wong and Sandy Middleton

Med J Aust 2019; 211 (10): 454-459 Free

Letters

Diabetic ketoacidosis with sodium–glucose cotransporter type 2 inhibitors: a case series

Gina McLachlan, Claire Keith and Albert Frauman

Med J Aust 2019; 211 (5): 237-237.e1

Perspectives

Controversies in medicine: redefining the diagnosis of type 1 diabetes

Jennifer J Couper and Leonard C Harrison

Med J Aust 2019; 211 (4): 157-159.e1

Letters

Updated prevalence of monogenic diabetes in Australia: Fremantle Diabetes Study Phase 2

Timothy ME Davis, Ashley E Makepeace, Kirsten Peters, Kevin Colclough and Wendy A Davis

Med J Aust 2019; 211 (4): 189-189.e1